Ana Cespedes
Directeur/Membre du Conseil chez ARGENX SE
Fortune : 84 396 $ au 30/04/2024
Profil
Dr. Ana Cespedes is an Independent Non-Executive Director at argenx SE, a Chief Operating Officer at International AIDS Vaccine Initiative, Inc., a Member of Congreso de los Diputados, a Member at Living Mindfulness SL, a Member at London School of Economics & Political Science and a Member-Oncology Data of National Institutes of Health.
She is on the Board of Directors at argenx SE and University of Navarra.
Dr. Cespedes was previously employed as a Managing Director by Merck Healthcare Foundation, a Senior Vice President-Global Marketing & Strategy by Merck KGAA Unsponsored ADR Facility, a Head-Corporate Affairs by Merck SL, a Managing Director by Serono Iberia, and a Co-Founder by Spanish Women Leaders Life Science.
She received her undergraduate degree from Universidad Complutense de Madrid, an MBA from the University of Navarra and a doctorate degree from Universidad Complutense de Madrid.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARGEN-X SE
0,00% | 20/02/2024 | 225 ( 0,00% ) | 84 396 $ | 30/04/2024 |
Postes actifs de Ana Cespedes
| Sociétés | Poste | Début |
|---|---|---|
| ARGENX SE | Directeur/Membre du Conseil | 12/12/2022 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Directeur des opérations | - |
| London School of Economics & Political Science | Corporate Officer/Principal | - |
| Congreso de los Diputados | Corporate Officer/Principal | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| University of Navarra | Directeur/Membre du Conseil | - |
Anciens postes connus de Ana Cespedes
| Sociétés | Poste | Fin |
|---|---|---|
Merck SL
 Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Corporate Officer/Principal | - |
| Merck KGAA Unsponsored ADR Facility | Sales & Marketing | - |
Formation de Ana Cespedes
| Universidad Complutense de Madrid | Doctorate Degree |
| University of Navarra | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Entreprise privées | 5 |
|---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
| Merck KGAA Unsponsored ADR Facility | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Health Technology |
| Congreso de los Diputados | Government |
